News Feature

A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.

To slow the spread of COVID-19, Stanford Medicine clinicians and patients are taking the traditional office visit online.

Researchers have developed a method for building nanoscale structures with genetically reprogrammed cells.

Prevented from gathering as a group because of COVID-19, Stanford medical students organized online events from their homes to mark Match Day, when they learned where they will continue their training.

The Stanford Blood Center urges those who are healthy, and who haven’t traveled to high-risk countries or been in contact with someone who has COVID-19, to donate blood.

Stanford’s test for COVID-19, caused by the novel coronavirus, is rapidly expanding capacity to serve patients in the Bay Area and beyond. Researchers hope to soon be able to process more than 1,000 tests per day.

Leaders of the Stanford School of Medicine, Stanford Health Care and Stanford Children’s Health answered questions about COVID-19 and discussed how Stanford Medicine is addressing the outbreak.

Drive-through appointments for Stanford Medicine’s COVID-19 test are available for patients who have been referred by their medical providers.

From migraines to strokes to brain bleeds, the symptoms of HHT are varied. Diagnosis is often delayed, yet early care can prevent both bothersome and deadly side effects.

The Stanford Clinical Virology Laboratory has deployed an in-house diagnostic test for the virus that causes COVID-19. Rapid identification of infected people could help limit the spread of the virus.